To examine this possibility, we re-introduced SPHK2 into the LV-miR-708 cells and observed that SPHK2 overexpression reversed the tumor-suppressing effects of miR-708 on glioma cells. The gene discussed is SPHK2; the disease is central nervous system cancer.